ロード中...
Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer
Metabolic reprogramming is increasingly recognised as one of the defining hallmarks of tumorigenesis. There is compelling evidence to suggest that endometrial cancer develops and progresses in the context of profound metabolic dysfunction. Whilst the incidence of endometrial cancer continues to rise...
保存先:
| 出版年: | Metabolites |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7463916/ https://ncbi.nlm.nih.gov/pubmed/32751940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/metabo10080314 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|